​

PROCEPT BioRobotics (PRCT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRCT Stock Forecast

PROCEPT BioRobotics (PRCT) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $28.83, with a high of $35.00 and a low of $20.00. This represents a 59.46% increase from the last price of $18.08.

$15 $32 $49 $66 $83 $100 High: $35 Avg: $28.83 Low: $20 Last Closed Price: $18.08

PRCT Stock Rating

PROCEPT BioRobotics stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (60.00%), 5 Hold (33.33%), 1 Sell (6.67%), and 0 Strong Sell (0.00%).

Buy
Total 15 0 1 5 9 Strong Sell Sell Hold Buy Strong Buy

PRCT Price Target Upside V Benchmarks

TypeNameUpside
StockPROCEPT BioRobotics59.46%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks20.26%

Price Target Trends

1M3M12M
# Anlaysts2515
Avg Price Target$22.50$27.80$41.93
Last Closing Price$18.08$18.08$18.08
Upside/Downside24.45%53.76%131.91%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26165-113
Jun, 26164-112
May, 26164-112
Apr, 26164-112
Mar, 26263-112
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 28, 2026UBS$20.00$17.6913.06%10.62%
Jul 02, 2026Truist Financial$25.00$21.0318.88%38.27%
Jun 24, 2026Vijay KumarEvercore ISI$30.00$20.6045.63%65.93%
Jun 11, 2026Leerink Partners$29.00$29.09-0.31%60.40%
Apr 30, 2026Matt O'BrienPiper Sandler$35.00$21.7161.22%93.58%
Feb 27, 2026Richard NewitterTruist Financial$30.00$22.6932.22%65.93%
Feb 26, 2026Nathan TreybeckWells Fargo$34.00$27.8422.13%88.05%
Dec 18, 2025Richard NewitterTruist Financial$47.00$34.2437.27%159.96%
Dec 12, 2025Danielle AntalffyUBS$62.00$36.0272.13%242.92%
Dec 02, 2025Patrick WoodMorgan Stanley$51.00$30.4167.71%182.08%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 28, 2026UBSBuyNeutraldowngrade
Jul 02, 2026CitigroupHolddowngrade
Jun 24, 2026Evercore ISIOutperforminitialise
Apr 30, 2026Piper SandlerOverweightOverweighthold
Mar 02, 2026UBSBuyBuyhold
Feb 26, 2026Cowen & Co.BuyBuyhold
Feb 26, 2026Wells FargoOverweightOverweighthold
Dec 12, 2025UBSBuyinitialise
Dec 02, 2025Morgan StanleyOverweightOverweighthold
Nov 05, 2025Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.37$-1.96$-2.24$-1.75$1.24---
Avg Forecast$-3.04$-1.88$-2.14$-1.74$-1.30$-0.76$-0.02$0.56
High Forecast$-2.93$-1.81$-2.08$-1.69$-1.04$-0.56$-0.02$0.58
Low Forecast$-3.12$-1.95$-2.23$-1.83$-1.55$-1.05$-0.02$0.54
Surprise %-54.93%4.26%4.67%0.57%-195.38%---

Revenue Forecast

$0 $130M $260M $390M $520M $650M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$34.47M$75.01M$136.19M$224.50M$308.05M---
Avg Forecast$33.37M$74.15M$134.44M$223.93M$315.00M$415.28M$516.98M$624.64M
High Forecast$34.07M$76.43M$138.14M$224.04M$318.36M$416.43M$528.59M$641.83M
Low Forecast$32.44M$72.02M$129.50M$223.77M$311.07M$414.13M$505.38M$601.68M
Surprise %3.31%1.16%1.30%0.25%-2.21%---

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-59.85M$-87.15M$-105.90M$-91.41M$-95.57M---
Avg Forecast$-143.66M$-88.84M$-101.72M$-83.22M$-70.45M$-43.55M$-1.10M$26.62M
High Forecast$-138.46M$-85.51M$-98.19M$-79.93M$-49.23M$-26.33M$-1.05M$27.57M
Low Forecast$-147.59M$-92.38M$-105.24M$-86.51M$-73.37M$-49.54M$-1.14M$25.35M
Surprise %-58.34%-1.90%4.11%9.85%35.66%---

PRCT Forecast FAQ

Is PROCEPT BioRobotics stock a buy?

PROCEPT BioRobotics stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that PROCEPT BioRobotics is a favorable investment for most analysts.

What is PROCEPT BioRobotics's price target?

PROCEPT BioRobotics's price target, set by 15 Wall Street analysts, averages $28.83 over the next 12 months. The price target range spans from $20 at the low end to $35 at the high end, suggesting a potential 59.46% change from the previous closing price of $18.08.

How does PROCEPT BioRobotics stock forecast compare to its benchmarks?

PROCEPT BioRobotics's stock forecast shows a 59.46% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (20.26%).

What is the breakdown of analyst ratings for PROCEPT BioRobotics over the past three months?

  • July 2026: 7.69% Strong Buy, 46.15% Buy, 38.46% Hold, 0% Sell, 7.69% Strong Sell.
  • June 2026: 8.33% Strong Buy, 50.00% Buy, 33.33% Hold, 0% Sell, 8.33% Strong Sell.
  • May 2026: 8.33% Strong Buy, 50.00% Buy, 33.33% Hold, 0% Sell, 8.33% Strong Sell.

What is PROCEPT BioRobotics’s EPS forecast?

PROCEPT BioRobotics's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.76, marking a -161.29% decrease from the reported $1.24 in 2025. Estimates for the following years are $-0.02 in 2027, and $0.56 in 2028.

What is PROCEPT BioRobotics’s revenue forecast?

PROCEPT BioRobotics's average annual revenue forecast for its fiscal year ending in December 2026 is $415.28M, reflecting a 34.81% increase from the reported $308.05M in 2025. The forecast for 2027 is $516.98M, and $624.64M for 2028.

What is PROCEPT BioRobotics’s net income forecast?

PROCEPT BioRobotics's net income forecast for the fiscal year ending in December 2026 stands at $-43.549M, representing a -54.43% decrease from the reported $-95.573M in 2025. Projections indicate $-1.096M in 2027, and $26.62M in 2028.